Leishmaniasis: An unpleasant holiday memory;Leishmaniasis: Een vervelende vakantieherinnering

Nederlands Tijdschrift voor Dermatologie en Venereologie

Volumn 15, Issue 6, 2005, Pages 270-276

  Van Der Snoek, E M ^a   De Waard Van Der Spek, F B ^a   Den Hollander, J C ^a   Munte, K ^a   Sluiters, J F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antimone therapy; L. braziliensis complex; Leishmaniasis; Sodium stibogluconate (Pentostam); Tropical ulcers

Indexed keywords

STIBOGLUCONATE SODIUM;

ADULT; ARTICLE; BOLIVIA; CASE REPORT; FEMALE; HUMAN; LEG ULCER; LEISHMANIASIS; LEISURE; PARASITISM; POLYMERASE CHAIN REACTION; PSYCHODIDAE; PUNCH BIOPSY;

EID: 23944504070     PISSN: 09258604     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Enk CD, Gardlo K, Hochberg M, et al. Kutane Leishmaniose. Hautarzt 2003;54:506-512.
2. Zeegelaar JE, Faber WR. Tien jaar cutane leishmaniasis in het AMC. Ned Tijdschr Derm Venereol 2004;14:206-207.
3. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-1199.
4. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996;34:257-272.
5. Bryceson ADM, Hay RJ. Parasitic worms and protozoa. In: Champion RH, Burton JL, Burns DA, Breathnach SM (Eds.). Textbook of Dermatology, 6e editie. Oxford: Blackwell Science Ltd, 1998:1410-1421.
6. Ashford RW. The leishmaniases as emerging and reemerging zoonoses. Int J Parasit 2000;30:1269-1281.
7. Sangüeza OP, Lu D, Sangüeza M, et al. Protozoa and worms. In: Bolognia JL, Jorizzo JL, Rapini RP (Eds.). Dermatology. Edinburgh: Elsevier Science, 2003:1295-1300.
8. Weina PJ, Neafie RC, Wortmann G, et al. Old world leishmaniasis: an emerging infection among deployed US military an civilian workers. Clin Infect Dis 2004;39:1674-1680.
9. Faber WR, Oskam L, Van Gool T, et al. Value of diagnostic techniques for cutaneous Leishmaniasis. J Am Acad Dermatol 2003;49:70-74.
10. Pirmez C, da Silva Trayano V, Paes-Oliveira Neto M, et al. Use of PCR in diagnosis of human American tegumentary Leishmaniasis in Rio de Janeiro, Brazil. J Clin Microbiol 1999;37:1819-1823.
11. Berman J. Current treatment approaches to Leishmaniasis. Curr Opin Infect Dis 2003;16:397-401.
12. Gardlo K, Horska Z, Enk CD, et al. Treatment of cutaneous Leishmaniasis by photodynamic therapy. J Am Acad Dermatol 2003;48:893-896.
13. Enk CD, Fritsch C, Jonas F, et al. Treatment of cutaneous Leishmaniasis with photodynamic therapy. Arch Dermatol 2003;139:432-434.
14. Sindermann H, Croft SL, Engel KR, et al. Miltefosine (Impavido): the first oral treatment against Leishmaniasis. Med Microbiol Immunol 2004;193:173-180.
15. Jha TK, Sundar S, Thakur CP, et al. Miltefosine, an oral agent, for the treatment of Indian visceral Leishmaniasis. N Engl J Med 1999;341:1795-1800.
16. Uzonna JE, Spath GF, Beverly SM, et al. Vaccination with phosphoglycan-deficient Leishmaniasis major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response. J Immunol 2004;172:3793-3797.
17. el-Hassan AM, Zijlstra EE. Leishmaniasis in Sudan. Mucosal Leishmaniasis. Trans R Soc Trop Med Hyg 2001;95:S19-26.
18. Sluiters JF. Leishmaniasis. In: Diagnostisch Kompas 2003. Amstelveen: College voor Zorgverzekeringen, 2003.
19. Guerin Ph J, Olliaro P, Sundar S, et al. Visceral Leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002;2:494-501.